Drug application

NILSTAT (NYSTATIN)

Drugs@FDA ANDA 061325 · LEDERLE

Key facts

Drug name NILSTAT
Active ingredients NYSTATIN
Application type ANDA
Application number 061325
Company LEDERLE
Dosage forms TABLET, VAGINAL
Strength 100,000 UNITS
Marketing status Discontinued
Reference listed drug No

At a glance

  • None Label versions
  • 1–9 Products
  • None Therapeutic equivalents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA applications

Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA

Browse all Drugs@FDA applications